P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy

$124,000R37FY2021CANIH

Methodist Hospital Research Institute, Houston TX

Investigators

Linked publications, trials & patents

Paper 39426662 Paper 38965409 Paper 38883270 Paper 38518774 Paper 36027915 Paper 34725506 Paper 34678150

View original record on NIH RePORTER →